MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,788 | -61.4% | 61,250 | 0.0% | 0.03% | -61.2% |
| Q2 2023 | $201,513 | -96.7% | 61,250 | -86.4% | 0.07% | -96.0% |
| Q2 2021 | $6,111,000 | -16.1% | 450,000 | 0.0% | 1.68% | -1.8% |
| Q1 2021 | $7,281,000 | -54.4% | 450,000 | -25.0% | 1.71% | -51.9% |
| Q4 2020 | $15,966,000 | -18.3% | 600,000 | -42.9% | 3.56% | -37.0% |
| Q3 2020 | $19,551,000 | +33.7% | 1,050,000 | +68.0% | 5.65% | +46.4% |
| Q2 2020 | $14,625,000 | +25.4% | 625,000 | -68.8% | 3.86% | +24.8% |
| Q1 2020 | $11,660,000 | +154.4% | 2,000,000 | +150.0% | 3.09% | +254.3% |
| Q4 2019 | $4,584,000 | -57.2% | 800,000 | +33.3% | 0.87% | -72.3% |
| Q2 2018 | $10,716,000 | +144.2% | 600,000 | +115.6% | 3.15% | +255.2% |
| Q1 2018 | $4,388,000 | – | 278,244 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |